POLAREAN IMAGING PLC
POLX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BF3DT583
- LEI:
- 213800DGR2BHXJ36OL37
- Country:
- United States of America
- Address:
- 2500 MERIDIAN PARKWAY, 27713 DURHAM
- Website:
- https://polarean.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Poolbeg Pharma develops and commercializes innovative medicines for unmet medical needs, focusing on cancer immunotherapy-induced CRS, infectious diseases, and metabolic conditions.Ê They strategically commercialize existing drugs to fund their pipeline and leverage AI to accelerate drug discovery.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-12 08:00 |
Legal Proceedings Report
Submission of new Phase III study protocol to FDA
|
English | 20.5 KB | |
| 2025-07-24 08:00 |
Remuneration Information
Block Listing Six Monthly Return
|
English | 22.2 KB | |
| 2025-06-24 08:00 |
Related Party Transaction
Promotion & sales representative agreement
|
English | 20.2 KB | |
| 2025-06-02 08:00 |
Regulatory News Service
FDA expands XENOVIEW indication
|
English | 21.0 KB | |
| 2025-05-15 13:48 |
Regulatory News Service
Xenon MRI featured prominently at ATS 2025
|
English | 51.6 KB | |
| 2025-05-14 15:25 |
Environmental & Social Information
Ongoing collaboration with Philips
|
English | 13.0 KB | |
| 2025-03-10 08:00 |
Regulatory News Service
Expansion of Xenon MRI imaging platform
|
English | 22.6 KB | |
| 2025-02-27 08:00 |
Earnings Release
FY24 trading update
|
English | 20.3 KB | |
| 2025-02-19 08:00 |
Regulatory News Service
Virtual Investor Day
|
English | 19.5 KB | |
| 2025-02-03 08:00 |
M&A Activity
Taiwanese distributor agreement with Sumtage
|
English | 18.7 KB | |
| 2025-01-30 08:00 |
Regulatory News Service
Key patent in China secured
|
English | 17.5 KB | |
| 2025-01-28 08:00 |
Regulatory News Service
Collaboration to Advance Lung Imaging Innovation
|
English | 22.2 KB | |
| 2025-01-24 08:00 |
Share Issue/Capital Change
Block Listing Six Monthly Return
|
English | 22.3 KB | |
| 2024-12-11 15:52 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.4 KB | |
| 2024-11-21 08:00 |
Regulatory News Service
FDA clears Chest Coil in GE HealthCare MRI Systems
|
English | 20.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
CHOSA Oncology AB | Sweden | CHOSA | |
|
Cinclus Pharma Holding AB | Sweden | CINPHA | |
|
Circio Holding ASA | Norway | CRNA | |
|
CIZZLE BIOTECHNOLOGY HOLDINGS PLC | United Kingdom | CIZ | |
|
CLAL Biotechnology Industries Ltd. | Israel | CBI | |
|
Combigene AB | Sweden | COMBI | |
|
Compugen Ltd. | Israel | CGEN | |
|
Corline Biomedical AB | Sweden | CLBIO | |
| CRISM Therapeutics Corporation | Virgin Islands (British) | N/A | ||
|
Curasight A/S | Denmark | CURAS |